Lilak v. Astrazenca Pharmaceutical-US Inc., Corporation, No. 1:2012cv00031 - Document 44 (D. Colo. 2012)
Court Description: FINAL JUDGMENT by Clerk re: 43 Order. By Clerk on 9/28/12. (mnfsl, )
Download PDF
<![CDATA[
Lilak v. Astrazenca Pharmaceutical-US Inc., Corporation Doc. 44 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Civil Action No. 12-cv-00031-PAB-MJW SAFDAR LILAK, Plaintiff, v. ASTRAZENCA PHARMACEUTICAL-US INC., CORPORATION, Defendant. FINAL JUDGMENT In accordance with orders filed during the pendency of this case, and pursuant to Fed. R. Civ. P. 58(a), the following Final Judgment is hereby entered. Pursuant to the Order (Doc #43) of Judge Philip A. Brimmer entered on September 26, 2012 it is ORDERED that the Recommendation of United States Magistrate Judge [Docket No. 33] is ACCEPTED. It is further ORDERED that Defendant AstraZeneca Pharmaceutical-US Inc., Corporation’s [AstraZeneca Pharmaceutical, LP] Motion to Dismiss [Docket No. 6] is GRANTED. It is further ORDERED that this case is dismissed in its entirety. DATED at Denver, Colorado, this 28th day of September, 2012. FOR THE COURT: JEFFREY P. COLWELL, CLERK By: s/Edward P. Butler Edward P. Butler, Deputy Clerk Dockets.Justia.com
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
